Akanda (AKAN) vs Ispire Technology (ISPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ispire Technology is the larger company by market cap ($84.3 million vs $4.7 million), about 17.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AKAN | ISPR |
|---|---|---|
| Share price | $1.78 | $1.46 |
| Market cap | $4.70M | $84.32M |
| 1-day change | -7.77% | +3.55% |
| YTD return | — | -49.64% |
| 1-year return | — | -38.96% |
| Forward P/E | — | 73.00 |
| EPS (TTM) | $-14,935.32 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $78.90 | $3.87 |
| 52-week low | $1.73 | $1.01 |
| Distance from 52-week high | -97.74% | -62.27% |
| Average volume | 1.35M | 35.98K |
| Shares outstanding | 2.39M | 57.75M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ispire Technology is about 17.9 times larger than Akanda by market value ($84.32M vs $4.70M).
AKAN vs ISPR FAQ
Which is bigger, Akanda or Ispire Technology?
Ispire Technology (ISPR) is larger, with a market capitalization of $84.32M compared with $4.70M for Akanda (AKAN).
Are Akanda and Ispire Technology in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.